Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19128831rdf:typepubmed:Citationlld:pubmed
pubmed-article:19128831lifeskim:mentionsumls-concept:C0023487lld:lifeskim
pubmed-article:19128831lifeskim:mentionsumls-concept:C0230463lld:lifeskim
pubmed-article:19128831lifeskim:mentionsumls-concept:C1704257lld:lifeskim
pubmed-article:19128831lifeskim:mentionsumls-concept:C1704258lld:lifeskim
pubmed-article:19128831lifeskim:mentionsumls-concept:C1442161lld:lifeskim
pubmed-article:19128831lifeskim:mentionsumls-concept:C0449560lld:lifeskim
pubmed-article:19128831lifeskim:mentionsumls-concept:C1533148lld:lifeskim
pubmed-article:19128831lifeskim:mentionsumls-concept:C1517945lld:lifeskim
pubmed-article:19128831pubmed:issue10lld:pubmed
pubmed-article:19128831pubmed:dateCreated2009-7-6lld:pubmed
pubmed-article:19128831pubmed:abstractTextAcute promyelocytic leukemia (APL) is characterized by the presence of a chromosomal rearrangement involving retinoic acid receptor alpha (RARalpha) gene generating the X-RARalpha fusion. We describe here a unique RARalpha gene rearrangement in a patient with M3r subtype of APL. Conventional cytogenetic analysis revealed Y-chromosome loss as the sole karyotypic anomaly. No X-RARalpha fusion was detected by fluorescence in situ hybridization (FISH) using PML/RARalpha dual-color dual-fusion translocation probe set, or RARalpha dual-color break apart rearrangement probe or reverse-transcription polymerase chain reaction (RT-PCR). However, FISH using RARalpha dual-color break apart rearrangement probe showed a deletion of the entire 3'-end of one allele of RARalpha gene. To our knowledge, this is the first documented APL with 3'RARalpha submicroscopic deletion which is not associated with X-RARalpha fusion. The molecular consequences of this anomaly remain to be elucidated.lld:pubmed
pubmed-article:19128831pubmed:languageenglld:pubmed
pubmed-article:19128831pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19128831pubmed:citationSubsetIMlld:pubmed
pubmed-article:19128831pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19128831pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19128831pubmed:statusMEDLINElld:pubmed
pubmed-article:19128831pubmed:monthOctlld:pubmed
pubmed-article:19128831pubmed:issn1873-5835lld:pubmed
pubmed-article:19128831pubmed:authorpubmed-author:ZhangJunJlld:pubmed
pubmed-article:19128831pubmed:authorpubmed-author:XueYongquanYlld:pubmed
pubmed-article:19128831pubmed:authorpubmed-author:PanJinlanJlld:pubmed
pubmed-article:19128831pubmed:authorpubmed-author:WuYafangYlld:pubmed
pubmed-article:19128831pubmed:authorpubmed-author:HanYongshengYlld:pubmed
pubmed-article:19128831pubmed:authorpubmed-author:BaiShuxiaoSlld:pubmed
pubmed-article:19128831pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19128831pubmed:volume33lld:pubmed
pubmed-article:19128831pubmed:ownerNLMlld:pubmed
pubmed-article:19128831pubmed:authorsCompleteYlld:pubmed
pubmed-article:19128831pubmed:pagination1433-5lld:pubmed
pubmed-article:19128831pubmed:meshHeadingpubmed-meshheading:19128831...lld:pubmed
pubmed-article:19128831pubmed:meshHeadingpubmed-meshheading:19128831...lld:pubmed
pubmed-article:19128831pubmed:meshHeadingpubmed-meshheading:19128831...lld:pubmed
pubmed-article:19128831pubmed:meshHeadingpubmed-meshheading:19128831...lld:pubmed
pubmed-article:19128831pubmed:meshHeadingpubmed-meshheading:19128831...lld:pubmed
pubmed-article:19128831pubmed:meshHeadingpubmed-meshheading:19128831...lld:pubmed
pubmed-article:19128831pubmed:meshHeadingpubmed-meshheading:19128831...lld:pubmed
pubmed-article:19128831pubmed:meshHeadingpubmed-meshheading:19128831...lld:pubmed
pubmed-article:19128831pubmed:meshHeadingpubmed-meshheading:19128831...lld:pubmed
pubmed-article:19128831pubmed:meshHeadingpubmed-meshheading:19128831...lld:pubmed
pubmed-article:19128831pubmed:meshHeadingpubmed-meshheading:19128831...lld:pubmed
pubmed-article:19128831pubmed:meshHeadingpubmed-meshheading:19128831...lld:pubmed
pubmed-article:19128831pubmed:meshHeadingpubmed-meshheading:19128831...lld:pubmed
pubmed-article:19128831pubmed:year2009lld:pubmed
pubmed-article:19128831pubmed:articleTitleY-chromosome loss as the sole karyotypic anomaly with 3'RARalpha submicroscopic deletion in a case of M3r subtype of acute promyelocytic leukemia.lld:pubmed
pubmed-article:19128831pubmed:affiliationThe First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis, 188 Shizi Street, Suzhou, 215006, PR China.lld:pubmed
pubmed-article:19128831pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19128831pubmed:publicationTypeCase Reportslld:pubmed
pubmed-article:19128831pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:5914entrezgene:pubmedpubmed-article:19128831lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:19128831lld:entrezgene